Short-term effects of focal argon laser treatment in diabetic maculopathy as demonstrated by optical coherence tomography

Retina

Volumn 27, Issue 1, 2007, Pages 13-20

  Sandhu, Sukhpal S ^a   Birch, Michael K ^a   Griffiths, Philip G ^a   Talks, Stephen J ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Argon laser; Diabetic maculopathy; Optical coherence tomography; Retinal thickness

Indexed keywords

ADULT; AGED; ARGON LASER; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; EYE EXAMINATION; FEMALE; HUMAN; LOW LEVEL LASER THERAPY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RETINA; RETINA MACULOPATHY; STATISTICAL SIGNIFICANCE; THICKNESS; TREATMENT OUTCOME;

ADULT; AGED; ANTHROPOMETRY; DIABETIC RETINOPATHY; FEMALE; HUMANS; LASER SURGERY; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 33846263966     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iae.0000256657.64240.a1     Document Type: Article

References (19)

1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macula edema. Report number 1. Arch Ophthalmol 1985;103:1796-1806.
2. Toth CA, Birngruber R, Boppart SA, et al. Argon laser retinal lesions evaluated in vivo by optical coherence tomography. Am J Ophthalmol 1997;123:188-198.
3. Massin P, Erginay A, Haouchine B, et al. Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software. Eur J Ophthalmol 2002;12:102-108.
4. Rivellese M, George A, Sulkes D, et al. Optical coherence tomography after laser photocoagulation for clinically significant macular edema. Ophthalmic Surg Lasers 2000;31:192-197.
5. Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 2002;22:759-767.
6. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 1995;113:1019-1029.
7. Massin P, Vicaut E, Haouchine B, et al. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 2001;119:1135-1142.
8. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999;127:688-693.
9. Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998;105:360-370.
10. Schaudig UH, Glaefke C, Scholz F, Richard G. Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema. Ophthalmic Surg Lasers 2000;31:182-186.
11. Strom C, Sander B, Larsen N, et al. Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Invest Ophthalmol Vis Sci 2002;43:241-245.
12. Yang CS, Cheng CY, Lee FL, et al. Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography. Acta Ophthalmol Scand 2001;79:266-270.
13. Giovannini A, Amato G, Mariotti C, Scassellati-Sforzolini B. Optical coherence tomography findings in diabetic macular edema before and after vitrectomy. Ophthalmic Surg Lasers 2000;31:187-191.
14. Toth CA, Narayan DG, Boppart SA, et al. A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. [Erratum appears in Arch Ophthalmol 1998;116:77]. Arch Ophthalmol 1997;115:1425-1428.
15. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927.
16. Sahni J, Stanga P, Wong D, Harding S. Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study. Br J Ophthalmol 2005;89:316-320.
17. Frank RN, Schulz L, Abe K, Iezzi R. Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology 2004;111:211-217.
18. Lobo CL, Bernardes RC, Cunha-Vaz JG. Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes. Arch Ophthalmol 2000;118:1364-1369.
19. Lobo CL, Bernardes RC, Figueira JP, et al. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy. Arch Ophthalmol 2004;122:211-217.